长效胰岛素联合口服降糖药治疗2型糖尿病的疗效

本研究旨在探究观察长效胰岛素联合口服降糖药治疗2型糖尿病的疗效。方法 在获得相关标准,且患者签署了知情同意书后,本院通过随机排序分组的方法将80例患者分为两大组。两大组中,40例对照组患者采用长效胰岛素治疗,40例实验组患者在对照组的基础上采用联合口服降糖药的方式治疗。实验过程中对患者的数据指标详细记录,再通过SPSS软件进行对比分析,来观察患者之间的疗效情况。结果 通过分析发现,实验组患者在经过联合治疗后其血糖水平更低,尿微量更少,临床疗效上有效率更高P<0.05。结论 在2型糖尿病患者的治疗过程中采用联合治疗比单纯采用胰岛素治疗的效果更高,值得推广应用。

中医保健疗法治疗脾胃虚弱型小儿厌食症疗效观察

本研究旨在观察中医保健疗法治疗脾胃虚弱型小儿厌食症的疗效。方法 获得委员会批准和患儿及其亲属同意后,本院采取随机数乱序法方式将100例脾胃虚弱型小儿厌食症患儿分为对照组和实验组。其中,对照组50例患儿,采用常规治疗方式,实验组50例患儿,采用中医保健疗法。再对过程中的实验数据详细记录,对比两组患儿的临床疗效、D—木糖吸收率等。结果 与对照组相比,实验组患儿临床疗效有效率更高,P<0.05。并且实验组患儿的D—木糖吸收率更高,部分血微量元素含量更高,P<0.05。结论 中医保健疗法对脾胃虚弱型小儿厌食症患儿的治疗效果有积极的促进作用,值得推广应用。

中西医结合治疗急性胰腺炎效果分析

本研究旨在观察分析中西医结合治疗急性胰腺炎的效果。方法获得委员会批准和患者及其亲属同意后,本院采取随机数乱序法方式将60例急性胰腺炎患者分为对照组和实验组。其中,对照组30例患者,采用常规西医方式治疗,实验组30例患者,采用中西医结合方式治疗。再对过程中的实验数据详细记录,对比两组患者的临床疗效、临床指标。结果 与对照组相比,实验组患者临床疗效有效率更高,P<0.05。并且实验组患者腹痛改善时间更短,临床指标更好,P<0.05。结论 中西医结合治疗对急性胰腺炎患者的治疗效果有积极的促进作用,值得推广应用。

The clinical observation of neoadjuvant chemotherapy in locally advanced breast cancer with DX regimen

The recent clinical curative effect and adverse events of docetaxel and capecitabine （DX） of neo- adjuvant chemotherapy in patients with locally advanced breast cancer was discussed. Methods： The data of 72 cases of neoadjuvant chemotherapy （DX） in locally advanced breast cancer after 4 cycles were retrospectively analyzed. Docetaxel 75 mg/m^2 by infusion 1 h on dl, capecitabine 2000 mg/m^2 by oral for twice daily on d1-14, 21 days was a cycle. Results： All 72 patients were assessed for efficacy and adverse events. The total effective rate was 80.5% （58/72）, including pathological complete response （pCR） was 7 （9.7%）, clinical complete remission （cCR） was 15（20.8%）, clinical partial response （PR） was 43 （59.7%）, stable disease （SD） was 8 （11.1%） and progressive disease （PD） was 6 （8.3%）. The main adverse events were gastrointestinal reactions and bone marrow suppression. The 3 to 4 degrees of adverse reactions including granulocytopenia in 7 patients （20.6%）, hand-foot syndrome in 6 patients （15.2%）. Conclusion： The DX regimen provide a favorable efficacy and safety profile in patients with locally advanced breast cancer for neoadjuvant chemotherapy.

Observation on Therapeutic Effect of Mild Moxibustion plus Acupoint Injection for Optic Atrophy

Objective： To observe the clinical effect of mild moxibustion plus acupoint injection for optic atrophy. Methods： Ninety-four patients with optic atrophy were divided into a treatment group （51 cases） and a control group （43 cases）. The treatment group was treated with mild moxibustion plus acupoint injection, and the control group was treated with medications. After three courses, the change of vision was observed. Results： The total effective rate was 82.4% in the treatment group and 41.9% in the control group, with a statistical difference between the two groups （P〈O.05）. Conclusion： Moxibustion plus acupoint injection is an effective method to treat optic atrophy.

44 Cases of Peripheral Facial Paralysis Treated by the SXDZ-100 Nerve and Muscle Stimulator

Objective: To observe the clinical effects of the Hua Tuo Manual Acupuncture Therapeutic Stimulator for peripheral facial paralysis. Methods: 87 patients with peripheral facial paralysis were divided randomly into the SXDZ-100 Nerve and Muscle Stimulator treatment group (44 cases) and the G6805 Electric Stimulator control group (43 cases). The acupoints selected for both the two groups were local points as well as distal points as Hegu (LI 4), Waiguan (TE 5), Sanyinjiao (SP 6), Taichong (LR 3). Effectiveness was compared between the two groups. Results: Both groups had a total effective rate of 100%. But the cure rate was 90.9% in the treatment group, and 73.0% in the control group, indicating a significant difference (P<0.05). No side effects were found in either of the two groups. Conclusion: The SXDZ-100 stimulator is more effective than the G6805 electroacupuncture stimulator for treatment of peripheral facial paralysis.